Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis
Completed
- Conditions
- Rheumatoid Arthritis
- Registration Number
- NCT02008266
- Lead Sponsor
- Hoffmann-La Roche
- Brief Summary
This non-interventional, descriptive, cross-sectional and multicenter study will examine the treatment of rheumatoid arthritis progressing for less than two years in the Algerian population. Current drug therapy as well as disease status and patient function will be assessed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 532
Inclusion Criteria
- Rheumatoid arthritis progressing for < 2 years.
Exclusion Criteria
- Rheumatoid arthritis progressing for < 3 months.
- Rheumatoid arthritis onset at < 18 years of age.
- Participation in another clinical study.
- Rheumatoid arthritis related connective tissue disorder.
- Any neuropsychological disorders.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Describe medications used in the treatment of rheumatoid arthritis with < 2 years' progression. Single observational visit [Day 1]
- Secondary Outcome Measures
Name Time Method Measure disease activity using DAS 28 assessment. Single observational visit [Day 1] Assess joint damage using the modified SHARP method. Single observational visit [Day 1] Assess functional status of patients using the Health Assessment Questionnaire (HAQ). Single observational visit [Day 1]